Ethyl Acetate

Ethyl Acetate

SCHEMBL284481

CCOC(C)=O.ClC(Cl)Cl.ClC(Cl)Cl

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.78
▸ LMNA P02545 1/20 0.78
▸ HSD17B10 Q99714 1/20 0.78
▸ TSHR P16473 1/20 0.48
▸ GAA P10253 2/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ MGAM O43451 1/20 0.43
▸ SI P14410 1/20 0.43
▸ MGAM2 Q2M2H8 1/20 0.43
▸ SOAT1 P35610 1/20 0.43
▸ TRPA1 O75762 1/20 0.40
▸ GLO1 Q04760 1/20 0.39
▸ CA12 O43570 2/20 0.38
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA9 Q16790 2/20 0.38
▸ CHRM5 P08912 2/20 0.37
▸ CHRM1 P11229 2/20 0.37
▸ CHRM3 P20309 2/20 0.37
▸ PGR P06401 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL5694224 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL697797 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL4011115 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL736472 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1919444 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1121012 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1671817 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1577562 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1121229 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL7573225 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240150367-A1 NITROGEN-CONTAINING SPIRO CYCLIC COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2024-05-09 — — US disclosed
US-20230023377-A1 NITROGEN-CONTAINING SPIRO CYCLIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF JAPAN TOBACCO INC. (JP) 2023-01-26 — — US disclosed
CN-115113478-A Colored resin composition 住友化学株式会社 2022-09-27 — — CN disclosed
US-20220256902-A1 NOVEL STEVIOL GLYCOSIDE, METHOD FOR PRODUCING SAME, AND SWEETENER COMPOSITION CONTAINING SAME SUNTORY HOLDINGS LIMITED (JP) 2022-08-18 — — US disclosed
EP-4011214-A1 BEVERAGE HAVING FOAM RETENTIVITY AND METHOD FOR IMPROVING FOAM RETENTIVITY OF BEVERAGE Suntory Holdings Limited (JP) 2022-06-15 — — EP disclosed
EP-4005371-A1 PLANT BODY CONTAINING NOVEL STEVIOL GLYCOSIDE Suntory Holdings Limited (JP) 2022-06-01 — — EP disclosed
EP-4006046-A1 NOVEL STEVIOL GLYCOSIDE, METHOD FOR PRODUCING SAME, AND SWEETENER COMPOSITION CONTAINING SAME Suntory Holdings Limited (JP) 2022-06-01 — — EP disclosed
EP-3858349-A1 NITROGEN-CONTAINING SPIRO-RING COMPOUND AND MEDICINAL USE OF SAME Japan Tobacco Inc. (JP) 2021-08-04 — — EP disclosed
EP-3438113-B1 TETRADENTATE LIGAND, AND PRODUCTION METHOD THEREFOR, SYNTHETIC INTERMEDIATE THEREOF, AND TRANSITION METAL COMPLEX THEREOF TAKASAGO PERFUMERY CO LTD (JP) 2021-02-17 — — EP disclosed
EP-2669353-B1 ANTIOXIDANT, ANTIOXIDANT COMPOSITION AND PRODUCTION METHOD THEREFOR WATANABE OYSTER LABORATORY CO LTD (JP) 2020-11-04 — — EP disclosed
US-5245037-A Synthetic bactericides WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1993-09-14 — — US disclosed
EP-0244697-B1 SILVER HALIDE COLOR PHOTOGRAPHIC MATERIAL FUJI PHOTO FILM CO., LTD. (JP) 1991-08-28 — — EP disclosed
EP-0393400-A1 Novel quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1990-10-24 — — EP disclosed
CN-1045971-A New Carbostyril derivative, their preparation method and the antiseptic-germicide that contains this analog derivative WAKUNAGA SEIYAKU KK (JP) 1990-10-10 — — CN disclosed
US-4818816-A ANTICOAGULANT CHOAY, S.A. (FR) 1989-04-04 — — US disclosed
US-4746602-A FREE FROM WHITE BACKGROUND STAINS FUJI PHOTO FILM CO., LTD. (JP) 1988-05-24 — — US disclosed
US-4729942-A PREVENTING EARLY COLOR DIFFUSION BY USING A DYE DEVELOPER HAVING A DYE MOITY HAVING A HYDROLYZABLE ESTER BALLAST GROUP; PHOTOTHERMOGRAPHY; SILVER HALIDES; FUJI PHOTO FILM CO., LTD. (JP) 1988-03-08 — — US disclosed
US-4710564-A ANTITUMOR AND -CARCINOGENIC AGENTS; NONTOXIC MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 1987-12-01 — — US disclosed
EP-0244697-A2 Silver halide color photographic material FUJI PHOTO FILM CO., LTD. (JP) 1987-11-11 — — EP disclosed
US-4367230-A ANTIANOXIC AGENTS TANABE SEIYAKU CO., LTD. (JP) 1983-01-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220256902-A1 NOVEL STEVIOL GLYCOSIDE, METHOD FOR PRODUCING SAME, AND SWEETENER COMPOSITION CONTAINING SAME SLC5A1, SLC5A2, UGGT1 ALDH1A1 597/4885LMNA 4866/4885HSD17B10 535/4885
US-20230023377-A1 NITROGEN-CONTAINING SPIRO CYCLIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF REN, PKD1, NPR1 ALDH1A1 985/4885LMNA 4175/4885HSD17B10 2597/4885
US-20240150367-A1 NITROGEN-CONTAINING SPIRO CYCLIC COMPOUNDS AND PHARMACEUTICAL USE THEREOF REN, PKD1, NPR1 ALDH1A1 936/4885LMNA 4098/4885HSD17B10 2549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback